# Efficacy of Hemostatic Powder in Preventing Bleeding After Gastric Endoscopic Submucosal Dissection in High-risk Patients: A Prospective Randomized Control Study

> **NCT03169569** · NA · COMPLETED · sponsor: **Yonsei University** · enrollment: 143 (actual)

## Conditions studied

- High-risk Patients for Post-ESD Bleeding

## Interventions

- **PROCEDURE:** Endo-clot™ (EndoClot Plus, Unc., Santa Clara, CA, USA) group
- **PROCEDURE:** Hemostatic forceps Only (Coagrasper®, Olympus, Japan) group

## Key facts

- **NCT ID:** NCT03169569
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-09-25
- **Final completion:** 2019-05-09
- **Target enrollment:** 143 (ACTUAL)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03169569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03169569, "Efficacy of Hemostatic Powder in Preventing Bleeding After Gastric Endoscopic Submucosal Dissection in High-risk Patients: A Prospective Randomized Control Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03169569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*